Stomach Diseases  >>  paclitaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
paclitaxel / Generic mfg.
NCT01904435: Cetuximab, Paclitaxel, Carboplatin And Radiation For Esophageal, Gastroesophageal Junction And Gastric Cancer

Completed
2
60
US
Chemotherapy/Radiation, Cetuximab, paclitaxel, carboplatin and radiation then surgery
Brown University, Bristol-Myers Squibb
Esophageal Cancer, Gastric Cancer
02/08
09/08
SHINE, NCT01457846 / 2010-023377-19: Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Terminated
2
960
Japan, Canada, Europe, RoW
AZD4547, paclitaxel
AstraZeneca
Gastro-oesophageal Junction Cancer, Gastric Cancer
08/13
02/15
NCT01774851 / 2012-003798-25: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach

Checkmark MM-111 plus paclitaxel and trastuzumab in HER2 expressing gastroesophageal cancers at ASCO 2016
Jun 2016 - Jun 2016: MM-111 plus paclitaxel and trastuzumab in HER2 expressing gastroesophageal cancers at ASCO 2016
Checkmark P2 trial enrollment was stopped based on a recommendation from the DSMB for the clinical trial
Feb 2015 - Feb 2015: P2 trial enrollment was stopped based on a recommendation from the DSMB for the clinical trial
Checkmark Solid tumors
More
Terminated
2
84
US
MM-111, Paclitaxel, Trastuzumab
Merrimack Pharmaceuticals
HER-2 Gene Amplification, Esophagus Cancer, Gastroesophageal Junction Cancer, Stomach Cancer
07/15
12/15
NCT02274012: Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment

Withdrawn
2
0
NA
Afatinib, BIBW 2992, Paclitaxel, Taxol
Columbia University, Boehringer Ingelheim
HER-2 Positive Gastric Cancer, Gastrooesophageal Cancer, Esophageal Cancer
08/15
08/15
NCT01746771: A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer

Completed
1/2
44
RoW
HM781-36B(Poziotinib), NOV120101, Poziotinib, Paclitaxel, Trastuzumab, Herceptin
Hanmi Pharmaceutical Company Limited, National OncoVenture
HER-2 Positive Advanced Gastric Cancer
08/15
08/15

Download Options